日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Pharmacological activation of STAT1-GSDME pyroptotic circuitry reinforces epigenetic immunotherapy for hepatocellular carcinoma

STAT1-GSDME 细胞焦亡通路药理学激活可增强肝细胞癌的表观遗传免疫疗法。

Tu, Yalin; Wu, Haoran; Zhong, Chengpeng; Liu, Yan; Xiong, Zhewen; Chen, Siyun; Wang, Jing; Wong, Patrick Pak-Chun; Yang, Weiqin; Liang, Zhixian; Lu, Jiahuan; Chen, Shufen; Zhang, Lingyun; Feng, Yu; Si-Tou, Willis Wai-Yiu; Yin, Baoyi; Lin, Yingnan; Liang, Jianxin; Liang, Liying; Vong, Joaquim S L; Ren, Weida; Kwong, Tsz Tung; Leung, Howard; To, Ka Fai; Ma, Stephanie; Tong, Man; Sun, Hanyong; Xia, Qiang; Zhou, Jingying; Kerr, David; La Thangue, Nick; Sung, Joseph J Y; Chan, Stephen Lam; Cheng, Alfred Sze-Lok

FADD Activation in Hepatocellular Carcinoma Potentiates CD8+ T-cell Responses and Sensitizes to Immune Checkpoint Inhibitors.

FADD 激活在肝细胞癌中增强 CD8+ T 细胞反应并增强对免疫检查点抑制剂的敏感性

Lu Jiahuan, Chan Thomas Ting-Hei, Wang Yun, Wang Jingya, Xiong Zhewen, Li Jingqing, Zhang Yixuan, Wang Huanyu, Chen Jintian, Yang Weiqin, Wang Jing, Tu Yalin, Leung Howard H W, Lung Raymond Wai Ming, Kang Wei, Tong Man, Wang Dan Michelle, Wu Qi-Nian, Zeng Zhao-Lei, Cheng Alfred Sze-Lok, To Ka-Fai, Chan Anthony W H, Zhou Jingying

Targeting PPAR-gamma counteracts tumour adaptation to immune-checkpoint blockade in hepatocellular carcinoma

靶向PPAR-γ可对抗肝细胞癌中肿瘤对免疫检查点阻断的适应性反应

Xiong, Zhewen; Chan, Stephen Lam; Zhou, Jingying; Vong, Joaquim S L; Kwong, Tsz Tung; Zeng, Xuezhen; Wu, Haoran; Cao, Jianquan; Tu, Yalin; Feng, Yu; Yang, Weiqin; Wong, Patrick Pak-Chun; Si-Tou, Willis Wai-Yiu; Liu, Xiaoyu; Wang, Jing; Tang, Wenshu; Liang, Zhixian; Lu, Jiahuan; Li, Ka Man; Low, Jie-Ting; Chan, Michael Wing-Yan; Leung, Howard H W; Chan, Anthony W H; To, Ka-Fai; Yip, Kevin Yuk-Lap; Lo, Yuk Ming Dennis; Sung, Joseph Jao-Yiu; Cheng, Alfred Sze-Lok